Ideeea Therapeutics

ideatx.com ↗ ·Madrid ·Seed

Ideeea Therapeutics (branded 'ideatx') is a Madrid-based biotech developing and manufacturing Advanced Therapy Medicinal Products (ATMPs) — allogeneic cell, gene and tissue-engineered therapies for regenerative and autoimmune medicine — covering the full value chain from R&D to GMP manufacturing. It was founded by healthcare executives from the Spanish pharma group FARMALIDER and its lead preclinical program is AGAcell®, an intradermal mesenchymal stem-cell formulation for androgenetic alopecia. The company raised a ~€2.3M seed round backed by private investors and Spain's CDTI under the EU NextGeneration/PERTE program.

Founded
2020
Founders
2
Total funds raised
€2.3M
Rounds
1
Investors
2
Last round
Jun 2025
SectorsBiotech, Cell & Gene Therapy, Advanced Therapy Medicinal Products (ATMPs), Regenerative Medicine, Pharma Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Suggest a correction

Founders

José Ángel Sánchez García
Chief Innovation Officer & Co-Founder
Marisa Berenguer Muñoz
CEO & Co-Founder

Global models 5

Sana Biotechnology
United States · sana.com ↗
Develops allogeneic cell and gene therapies, including for autoimmune and regenerative uses, and builds its own manufacturing: the same integrated R&D-to-manufacturing ATMP model.
$700MComparable
Allogene Therapeutics
United States · www.allogene.com ↗
Allogeneic cell-therapy developer that now also targets autoimmune disease and runs its own GMP cell-manufacturing plant.
$420MComparable
Century Therapeutics
United States · www.centurytx.com ↗
Makes allogeneic, stem-cell-derived cell therapies for autoimmune disease and cancer, covering the chain from discovery to manufacturing.
$410MComparable
Humacyte
United States · humacyte.com ↗
Tissue-engineered regenerative ATMP company that makes its own allogeneic off-the-shelf engineered tissue in in-house GMP facilities.
$375MComparable
Mesoblast
Allogeneic mesenchymal stem-cell therapy developer and manufacturer for inflammatory and regenerative conditions, the closest match to AGAcell's MSC approach.
$150MComparable

In the same niche 67 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 2

Open as list →

Funding rounds 1

DateRoundAmountLead
PublishedArticle
2025-11-21 ASEME reconoce a Marisa Berenguer por su proyecto biotecnológico contra la alopecia ↗
Pharmatech
2025-11-21
2025-08-10 Ideeea Therapeutics AGAcell: MSCs and ATP ↗
Hair Loss Cure 2020
2025-08-10
2025-07-10 Top 10 Startups – July 25 ↗
TSCFO
2025-07-10
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list